Delivery Order SPE2DB22D3301-SPE2DB25FY3RR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,937.65 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with a completion date of August 26, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and...
- The Defense Logistics Agency awarded a delivery order valued at $1,855.39 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication supplied in a 60-dose inhaler. The contract, awarded on October 31, 2025, with completion targeted for November 3, 2025, was competitively awarded with no set-aside designation. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $14,902.03 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with an ultimate completion date of October 29, 2025. This is a firm fixed-price, non-set-aside contract executed on October 28, 2025, with performance at the company's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $9,142.14 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination respiratory maintenance medication, with an ultimate completion date of August 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger federal contract vehicle. The place of performance is the vendor's Corporate Office location in...
- The Defense Logistics Agency awarded a delivery order valued at $13,326.39 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a respiratory maintenance medication supplied in a 60-dose package. This competitive, non-set-aside contract award was issued on September 3, 2025, with an ultimate completion date of September 4, 2025, reflecting a rapid fulfillment timeline typical of pharmaceutical supply orders. The contract employs firm fixed pricing and will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,064.29 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication supplied in a 60-dose inhaler. This firm fixed-price, non-set-aside delivery order was awarded on October 21, 2025, with an ultimate completion date of October 22, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $15,954.18 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication supplied in 60-dose inhalers. This firm fixed-price delivery order, issued on September 26, 2025, with an ultimate completion date of September 29, 2025, was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $2,658.71 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a respiratory maintenance medication supplied in a 60-dose inhaler configuration. Awarded on July 21, 2025, with completion targeted for July 22, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $6,633.02 to AmerisourceBergen Drug Corp on August 4, 2025, for TRELEGY ELLIPTA 100-62.5-25, a respiratory maintenance medication supplied in a 60-dose inhaler configuration. This is a firm fixed price, non-set-aside competitively awarded delivery order with an ultimate completion date of August 5, 2025, and performance based in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory maintenance medication, with a ceiling value of $9,948.57 under firm fixed price terms. The contract is classified as a child award issued on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This non-set-aside delivery order was...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY3RRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,729.62 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with an ultimate completion date of April 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract under a larger vehicle. The award was made to AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, which serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract enables the company to supply a broad portfolio of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, and vaccines across multiple therapeutic domains. The DLA awards to AmerisourceBergen reflect the company's demonstrated capability to meet federal procurement requirements and support healthcare systems serving the Defense Health Agency, U.S. Coast Guard, and other government entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 4/22/25 |